We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

News   Mar 12, 2018 | Original Story by Tim Stephens for the university of California Santa Cruz.

 
Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.

 
 
 

RELATED ARTICLES

Marker Indicates Those at Higher Risk from Lethal Fungal Spores

News

Genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

READ MORE

Probing Yeast Cells to Understand Cell Misregulation

News

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

READ MORE

Microbubbles Help Fight Against Dangerous Biofilms

News

Researchers have developed a system that harnesses the power of bubbles to propel tiny particles through the surfaces of tough bacterial biofilms and deliver an antiseptic deathblow to the microbes living inside.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE